Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Enanta Pharmaceuticals, Inc.”

218 pharma patents match "Enanta Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 218
Index total 30,257
Page 4 / 10

Quick answer

This filtered view shows 218 pharmaceutical patents matching "Enanta Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

218 results for “Enanta Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 10457703

    Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted

  2. US 10450306

    Isoxazole analogs as FXR agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  3. US 10442788

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  4. US 10428070

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted

  5. US 10407445

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted

  6. US 10398706

    Heteroaryldiazepine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Sep 3, 2019 · Expires Aug 29, 2039

    granted

  7. US 10323061

    Heteroaryl containing bile acid analogs as FXR/TGR5 agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted

  8. US 10301255

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted May 28, 2019 · Expires May 23, 2039

    granted

  9. US 10280175

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted May 7, 2019 · Expires May 2, 2039

    granted

  10. US 10266560

    Bile acid analogs as FXR/TGR5 agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  11. US 10246483

    Bile acid analogs as FXR/TGR5 agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Apr 2, 2019 · Expires Mar 28, 2039

    granted

  12. US 10208081

    Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  13. US 10189846

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted

  14. US 10179131

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

  15. US 10179792

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

  16. US 10144729

    Isoxazole analogs as FXR agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted

  17. US 10138228

    Isoxazole derivatives as FXR agonists and methods of use therof

    Enanta Pharmaceuticals, Inc. · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted

  18. US 10080743

    Isoxazole derivatives as FXR agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

  19. US 10080742

    Isoxazole derivatives as FXR agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

  20. US 10080741

    Isoxazole derivatives as FXR agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

  21. US 10034893

    5, 6-D2 uridine nucleoside/tide derivatives

    Enanta Pharmaceuticals, Inc. · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  22. US 10017499

    Benzimidazole derivatives

    Enanta Pharmaceuticals, Inc. · Granted Jul 10, 2018 · Expires Jul 5, 2038

    granted

  23. US 9957281

    Benzodiazepine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted May 1, 2018 · Expires Apr 26, 2038

    granted

  24. US 9765087

    Benzimidazole derivatives

    Enanta Pharmaceuticals, Inc. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.